574 related articles for article (PubMed ID: 30479097)
21. Prognostic role of hormone receptors in endometrial cancer: a systematic review and meta-analysis.
Zhang Y; Zhao D; Gong C; Zhang F; He J; Zhang W; Zhao Y; Sun J
World J Surg Oncol; 2015 Jun; 13():208. PubMed ID: 26108802
[TBL] [Abstract][Full Text] [Related]
22. ER and PR expression and survival after endometrial cancer.
Smith D; Stewart CJR; Clarke EM; Lose F; Davies C; Armes J; Obermair A; Brennan D; Webb PM; Nagle CM; Spurdle AB
Gynecol Oncol; 2018 Feb; 148(2):258-266. PubMed ID: 29217139
[TBL] [Abstract][Full Text] [Related]
23. [Effectiveness of tissue microarray technique for the assessment of estrogen and progesterone receptors expression in endometrioid endometrial cancer--preliminary report].
Gottwald L; Sek P; Kubiak R; Pasz-Walczak G; Piekarski J; Szwalski J; Suzin J; Tyliński W; Hendzel K; Jeziorski A
Ginekol Pol; 2012 May; 83(5):342-6. PubMed ID: 22708330
[TBL] [Abstract][Full Text] [Related]
24. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
Pasanen A; Tuomi T; Isola J; Staff S; Bützow R; Loukovaara M
Int J Gynecol Cancer; 2016 Oct; 26(8):1465-71. PubMed ID: 27648714
[TBL] [Abstract][Full Text] [Related]
25. Aromatase Inhibitors as Adjuvant Treatment for ER/PgR Positive Stage I Endometrial Carcinoma: A Retrospective Cohort Study.
Paleari L; Rutigliani M; Siri G; Provinciali N; Colombo N; Decensi A
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210157
[TBL] [Abstract][Full Text] [Related]
26. Stromal Clues in Endometrial Carcinoma: Loss of Expression of β-Catenin, Epithelial-Mesenchymal Transition Regulators, and Estrogen-Progesterone Receptor.
Senol S; Sayar I; Ceyran AB; Ibiloglu I; Akalin I; Firat U; Kosemetin D; Engin Zerk P; Aydin A
Int J Gynecol Pathol; 2016 May; 35(3):238-48. PubMed ID: 26367784
[TBL] [Abstract][Full Text] [Related]
27. [Relationship between the expression of dual specificity phosphatase-1 and the prognosis of endometrioid adenocarcinoma].
Gao BR; Yao YY; Chen YH; Li XP; Wang JL; Wei LH
Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2493-5. PubMed ID: 24300273
[TBL] [Abstract][Full Text] [Related]
28. Endometrial carcinoma: association of steroid hormone receptor expression with low angiogenesis and bcl-2 expression.
Sivridis E; Giatromanolaki A; Koukourakis M; Anastasiadis P
Virchows Arch; 2001 May; 438(5):470-7. PubMed ID: 11407475
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma.
Bildrici K; Tel N; Ozalp SS; Yalcin OT; Yilmaz V
Eur J Gynaecol Oncol; 2002; 23(6):540-4. PubMed ID: 12556100
[TBL] [Abstract][Full Text] [Related]
30. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
[TBL] [Abstract][Full Text] [Related]
31. Expression of ER, PR, and Her-2/neu in endometrial cancer: a clinicopathological study.
Srijaipracharoen S; Tangjitgamol S; Tanvanich S; Manusirivithaya S; Khunnarong J; Thavaramara T; Leelahakorn S; Pataradool K
Asian Pac J Cancer Prev; 2010; 11(1):215-20. PubMed ID: 20593959
[TBL] [Abstract][Full Text] [Related]
32. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
Lax SF; Pizer ES; Ronnett BM; Kurman RJ
Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
[TBL] [Abstract][Full Text] [Related]
33. Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium.
Halperin R; Zehavi S; Habler L; Hadas E; Bukovsky I; Schneider D
Eur J Gynaecol Oncol; 2001; 22(2):122-6. PubMed ID: 11446475
[TBL] [Abstract][Full Text] [Related]
34. Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival.
Mauland KK; Wik E; Hoivik EA; Kusonmano K; Halle MK; Berg A; Haugland HK; Øyan AM; Kalland KH; Stefansson IM; Akslen LA; Krakstad C; Trovik J; Werner HM; Salvesen HB
Oncotarget; 2017 Feb; 8(6):9696-9707. PubMed ID: 28039471
[TBL] [Abstract][Full Text] [Related]
35. The positivity of estrogen receptor and progesterone receptor may not be associated with metastasis and recurrence in epithelial ovarian cancer.
Chen S; Dai X; Gao Y; Shen F; Ding J; Chen Q
Sci Rep; 2017 Dec; 7(1):16922. PubMed ID: 29208958
[TBL] [Abstract][Full Text] [Related]
36. Clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma.
Li M; Zhao L; Shen D; Li X; Wang J; Wei L
Chin Med J (Engl); 2014; 127(8):1459-63. PubMed ID: 24762589
[TBL] [Abstract][Full Text] [Related]
37. The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration study.
van Weelden WJ; Reijnen C; Küsters-Vandevelde HVN; Bulten J; Bult P; Leung S; Visser NCM; Santacana M; Bronsert P; Hirschfeld M; Colas E; Gil-Moreno A; Reques A; Mancebo G; Huvila J; Koskas M; Weinberger V; Bednarikova M; Hausnerova J; Snijders MPLM; Matias-Guiu X; Amant F;
Hum Pathol; 2021 Mar; 109():80-91. PubMed ID: 33338506
[TBL] [Abstract][Full Text] [Related]
38. Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation.
Voss MA; Ganesan R; Ludeman L; McCarthy K; Gornall R; Schaller G; Wei W; Sundar S
Gynecol Oncol; 2012 Jan; 124(1):15-20. PubMed ID: 21864888
[TBL] [Abstract][Full Text] [Related]
39. Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma.
Li SF; Shiozawa T; Nakayama K; Nikaido T; Fujii S
Cancer; 1996 Jan; 77(2):321-9. PubMed ID: 8625241
[TBL] [Abstract][Full Text] [Related]
40. p53, estrogen and progesterone receptors in diagnostic curettage for endometrial adenocarcinoma and their correlation with morphological data and disease stage at hysterectomy.
Bonfitto VL; de Angelo Andrade LA
Sao Paulo Med J; 2003 Jul; 121(4):163-6. PubMed ID: 14595509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]